News

Biotechnology and health care conference in Grenoble, France

Biotechnology and health care conference in Grenoble, France

In February PBN was in Grenoble, France, as part of the SKALE2CT project, Together with 2 Hungarian med-tech companies,PNB were able to gather experience and build relationships. The knowledge and good practices gained there could be relevant for the CONNECTINGHEALTH project.

Digital Health Solutions
Ecosystems

 

The French city of Grenoble, one of Europe’s major research and innovation hubs,gathered up to launch its first massive tech event, Tech&fest.

 

The event is took place place at the AlpExpo centre on February 1-2 and was  themed around six areas:

●Tech and electronics industry

● Innovative solutions for businesses

● Energy, mobility, and the environment

● Space race

● Workplace quality of life, and the job market of the future

● Leisure and sports

An event at Alpexpo, the venue hosting tech&fest
An event at Alpexpo, the venue hosting tech&festAlpexpo

 

Keynote speakers included SpaceX Material Engineering VP Charles Kuehmann and Euro2Moon General Secretary Bertrand Baratte. They discussed the latest developments in the race to Mars and the Moon, ahead of a year packed with missions.

 

One of the most ambitious start-ups at the event was Spartan, a Marseille-based company that developed inflatable habitats for missions in space and underwater.

 

One of them is called Eurohab, and “is the only Lunar camp-base that fits within medium-sized landers, such as the ISA Argonaut,” founder Peter Weiss told Euronews Next.

 

“We hope it will help carry to the Moon the first European astronauts before 2030”.

Spartan Space's Eurohab, an inflatable habitat for missions on the surface of the Moon or Mars
Spartan Space’s Eurohab, an inflatable habitat for missions on the surface of the Moon or MarsSpartan Space

 

Green energy was also a crucial topic in Grenoble.

A “Decarbonisation Village” presented thirty solutions to help businesses cut their footprint through innovative packaging, design, and recycling, as well as AI.

 

ROSI Solar, a Grenoble company, showed how to minimise the impact of solar panels by reusing raw materials and recovering high-purity silicon and silver, which are usually lost at the end of a solar panel lifecycle.

 

“We recycle over 95 per cent of a panel after it’s dismissed, as well as materials used in its production process,” ROSI’s General Manager Antoine Chalaux told Euronews Next.

 

“The market has grown exponentially over the past two decades, and yet recycling activities are still not good enough. Most new panels are currently manufactured in China, Europe needs to become more self-sufficient, and our work is hopefully a step in that direction”.

 

Photovoltaic cells recycled by ROSI Solar
Photovoltaic cells recycled by ROSI SolarROSI/Franck Ardito

 

Hydrogen and nuclear energy owned an important panels too, including one about mini nuclear reactors, which  explained their energy, fuel-saving, and production benefits.

Tech&Fest was mainly open to business and start-up professionals.

 

NEWS​

Related News

Finland – Kuopio Health Ecosystem is ECHAlliance Ecosystem of the Month – July

15 Jul 2024
This month we are featuring our Finland - Kuopio Health Ecosystem as our Ecosystem of the Month.

EU JAMRAI- 2: Building a One Health World

15 Jul 2024
The mission at EU-JAMRAI 2 is to lead the fight against antimicrobial resistance (AMR) through joint and coordinated action across Europe.

Team MediBoost Wins AI4Health.Cro Innovation Competition

15 Jul 2024
Team MediBoost clinched the top prize at this year’s AI4Health.Cro innovation competition, winning €5,000 for their groundbreaking application designe...

Tackling obesity

8 Jul 2024
Apply for funding to develop effective strategies to tackle overweight and obesity. ‘Tackling obesity’ is open to applications submitted to the Popula...

Cancer research transatlantic development and skills enhancement award 2024

4 Jul 2024
Following the UK-US Cancer Summit, MRC and NIHR, in partnership with NCI, are launching a second competition for the cancer research transatlantic dev...

24/52 Liver Disease (EME Programme)

4 Jul 2024
The Efficacy and Mechanism Evaluation (EME) Programme is accepting Stage 1 applications to this funding opportunity.

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *